Results 241 to 250 of about 4,582,318 (310)

Recent advances in local anesthetic drug delivery systems based on natural polymers. [PDF]

Front Bioeng Biotechnol
Guo B, Zhou Q, Zhang X, Ma Q, Ma M, Wang T.   +5 more
europepmc   +1 more source

Long‐term culture of skin biopsies: maintenance of fibroblast production and competency of reprogramming

FEBS Open Bio, EarlyView.
Skin biopsies taken from a patient with an ultra‐rare disorder as well as controls were cultured for up to 473 days. The chunks of skin were serially transferred to a new culture plate when confluent with fibroblasts. Different generations of fibroblasts were analyzed for cell and molecular properties, proliferation, and competence for reprogramming to
Sudiksha Rathan‐Kumar, Michael A. Ripperger, Grant M. Westlake, Kevin C. Ess   +3 more
wiley   +1 more source

Targeting IBD treatment: smart drug delivery systems for oral administration. [PDF]

Mater Today Bio
Xu J, Tang P, Sun X, Song Y, Lin K, Jiang S, Yuan C.   +6 more
europepmc   +1 more source

Day/night variations of myeloid and lymphoid cell subsets in the murine inguinal lymph node

FEBS Open Bio, EarlyView.
The circadian system is involved in the temporal regulation of the immune system. Our study reveals that two innate immune populations, NKT cells and neutrophils, predominate at the beginning of the day in healthy mice, highlighting how the time of day influences immune responses.
Paula M. Wagner, César G. Prucca, Lucia Boffelli, Virginia A. Piqueras, Silvia G. Correa, Mariana Maccioni, Mario E. Guido   +6 more
wiley   +1 more source

SDMap: a comprehensive database of spatial drug perturbation maps. [PDF]

Nucleic Acids Res
Li F, Chen Z, Zhang Y, Ye X, Fan W, Kang A, Song X, Pei L, Qi Q, Liu W, Zha Z, Zhang Y, Zhang C, Xu Y.   +13 more
europepmc   +1 more source

Advances in microneedle Technology for Treatment of retinal degenerative diseases: a narrative review. [PDF]

Biomed Microdevices
Zong Y, Liu J, Yang M, Zhang J, Zou Y, Ye Z, Deng J, Gu W, Du J, Ohno-Matsui K, Kamoi K.   +10 more
europepmc   +1 more source

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA. [PDF]

Ther Adv Respir Dis
Höger P, Ries M, Olivares Rivera A, Ersöz H, Buschulte K, Fähndrich S, Kontogianni K, Herth F, Trudzinski FC.   +8 more
europepmc   +1 more source

Normality, Belonging and Welfare Inclusion among Young People with Drug Problems: A Commentary. [PDF]

Nordisk Alkohol Nark
Sylvin MG.
europepmc   +1 more source

Nanoparticles in HIV treatment for improved drug delivery, clinical translation, and future direction. [PDF]

Discov Nano
Terkimbi SD, Dangana RS, Mbina SA, Paul-Chima UO, Aja PM, Mujinya R.   +5 more
europepmc   +1 more source